An experimental protocol for a double-blind placebo-controlled evaluation of the effectiveness of oral naltrexone in management of adolescent eating disorders.
| Author | |
|---|---|
| Abstract |
:
This double-blind, placebo-controlled study evaluates the effectiveness of oral naltrexone in adolescents and young adults with eating disorders (EDs) characterized by purging with or without binge-eating behaviors. We hypothesize that participants receiving oral naltrexone will demonstrate greater improvements in body mass index in underweight participants and self-reported ED symptomatology compared to placebo. |
| Year of Publication |
:
2022
|
| Journal |
:
Contemporary clinical trials
|
| Volume |
:
122
|
| Number of Pages |
:
106937
|
| Date Published |
:
2022
|
| ISSN Number |
:
1551-7144
|
| URL |
:
https://linkinghub.elsevier.com/retrieve/pii/S1551-7144(22)00263-4
|
| DOI |
:
10.1016/j.cct.2022.106937
|
| Short Title |
:
Contemp Clin Trials
|
| Download citation |
